Eyebright Medical Technology Beijing Co Ltd (688050) — Cash Flow-to-Debt Ratio
Eyebright Medical Technology Beijing Co Ltd (688050) has a Cash Flow-to-Debt Ratio of 0.09x as of September 2025, meaning its operating cash flow of CN¥76.92 Million could theoretically repay 0% of its total liabilities (CN¥894.96 Million) in one year. See Eyebright Medical Technology Beijing Co (688050) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Eyebright Medical Technology Beijing Co Ltd Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Eyebright Medical Technology Beijing Co Ltd across 10 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Eyebright Medical Technology Beijing Co .
Annual Cash Flow-to-Debt Ratio for Eyebright Medical Technology Beijing Co Ltd (2016–2025)
Year-by-year debt coverage analysis for Eyebright Medical Technology Beijing Co Ltd. Check cash flow quality index of Eyebright Medical Technology Beijing Co to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.40x | CN¥369.15 Million | CN¥917.65 Million | ▼ -0.2% |
| 2024 | 0.40x | CN¥347.75 Million | CN¥862.71 Million | ▲ +25.7% |
| 2023 | 0.32x | CN¥226.27 Million | CN¥705.85 Million | ▼ -58.4% |
| 2022 | 0.77x | CN¥250.13 Million | CN¥324.30 Million | ▲ +8.1% |
| 2021 | 0.71x | CN¥219.30 Million | CN¥307.46 Million | ▼ -47.4% |
| 2020 | 1.36x | CN¥123.35 Million | CN¥90.89 Million | ▲ +2.8% |
| 2019 | 1.32x | CN¥50.49 Million | CN¥38.26 Million | ▲ +35.2% |
| 2018 | 0.98x | CN¥31.82 Million | CN¥32.59 Million | ▲ +1726.2% |
| 2017 | 0.05x | CN¥4.15 Million | CN¥77.62 Million | ▲ +172.8% |
| 2016 | -0.07x | CN¥-3.37 Million | CN¥45.88 Million | — |